Women whose cervix shortens after the 24‑week mark may be at higher risk of spontaneous preterm birth, a new analysis suggests, highlighting a potential window for detection that extends beyond the traditional second‑trimester scan.
Study Finds Cervical Length Below 26 mm Predicts Preterm Birth After 24 Weeks
The systematic review and meta‑analysis, published in the American Journal of Obstetrics and Gynecology, pooled data from 16 studies covering 26,776 pregnancies. Researchers compared transvaginal cervical length (TVCL) measurements taken between 24 + 0 and 36 + 6 weeks in women who later delivered before 37 weeks and those who gave birth at term.
Across the sample, women who experienced spontaneous preterm birth (SPTB) had consistently shorter cervixes. Between 24 + 0 and 28 + 6 weeks, the average TVCL was 5.47 mm shorter for those delivering before 37 weeks and 7.85 mm shorter for births before 34 weeks, both differences statistically significant (p < .001). A similar gap persisted at 27 + 0 to 32 + 6 weeks, with mean differences of 4.41 mm and 7.75 mm respectively.
By the later window of 31 + 0 to 36 + 6 weeks, the length gap narrowed; the mean difference of 4.71 mm was not statistically significant (p = .09). The pattern held true regardless of whether women had known risk factors for SPTB or which specific TVCL measurement technique was used.
Related: User Blocked by Online Platform
Optimal Cutoff Offers Strong Predictive Value
Using the Youden index, the investigators identified a TVCL threshold of 25.5 mm to 26.0 mm after 24 + 0 weeks as the most accurate predictor. At this cutoff, the pooled sensitivity was 0.74 and specificity reached 0.92. The positive likelihood ratio of 7.75 and diagnostic odds ratio of 28.1 suggest that a short cervix in the third trimester can markedly raise the odds of SPTB.
These findings support the clinical utility of continued cervical surveillance in asymptomatic women, especially those whose second‑trimester scans did not reveal a short cervix. Current guidelines already recommend vaginal progesterone or cervical cerclage for women with a second‑trimester TVCL under 25 mm; the new data suggest that a similar approach might be warranted later in pregnancy for a broader group.
Why the Extended Monitoring Matters
Preterm birth, defined as delivery before 37 + 0 weeks, accounts for roughly 75 % of perinatal deaths and remains the leading cause of death among children under five. The global preterm birth rate has hovered around 10 % for years, translating to an estimated 13.4 million preterm infants in 2020. While many cases are identified early, a sizable portion of women who deliver prematurely do not exhibit a short cervix in the second trimester.
In practice, the ability to spot accelerated cervical shortening after 24 weeks could give clinicians an important window to intervene. Earlier detection may allow for timely administration of progesterone, placement of a cerclage, or other preventative strategies, potentially reducing the incidence of SPTB.
Third‑trimester screening could save lives.
Related: Sore Eyes Identified as Common COVID-19 Symptom
From a broader perspective, extending cervical monitoring aligns with ongoing efforts to refine risk stratification in obstetrics. As health systems aim to lower preterm birth rates, incorporating third‑trimester TVCL checks could become a cost‑effective addition to prenatal care, especially in settings where resources for intensive neonatal support are limited.
Methodology and Study Quality
The authors performed an extensive search of PubMed, MEDLINE, and the Cochrane Library up to June 2025, without language restrictions. Eligible studies were cohort or cross‑sectional designs that reported TVCL after 24 + 0 weeks in asymptomatic women and allowed construction of 2 × 2 tables. Exclusions included studies of symptomatic patients, twin pregnancies, transabdominal measurements, abstracts, and duplicate data.
Out of 3,641 identified articles, the 16 that met inclusion criteria were assessed using the Newcastle‑Ottawa Scale. The analysis employed an inverse‑variance method with a random‑effects model to calculate mean differences, ensuring that variability across studies was accounted for.
All included investigations excluded iatrogenic preterm births, focusing solely on spontaneous cases. Consistency was observed across subgroups, reinforcing the robustness of the pooled estimates.
Implications for Clinical Practice
Given the high specificity of the 25.5 mm cutoff, clinicians can be relatively confident that a cervix longer than this threshold is unlikely to predict imminent SPTB. Conversely, a measurement below the cutoff signals a markedly increased risk, prompting consideration of interventions that have demonstrated efficacy in earlier gestational windows.
Related: Medicaid Member Engagement: Enhancing Health Outcomes and Member Experience
Healthcare providers may need to adjust prenatal protocols to incorporate routine TVCL assessments beyond 24 weeks, particularly for women who lacked a short cervix in the second trimester. Such a shift would require training, equipment allocation, and clear guidelines to standardize measurement techniques.
For patients, the added surveillance could mean more frequent appointments and possibly earlier initiation of therapies that were previously reserved for high‑risk groups identified earlier in pregnancy.
While the study does not address the cost‑benefit balance of universal third‑trimester screening, its findings provide a data‑driven foundation for policymakers to evaluate the potential health gains against resource demands.
Further research may explore how these TVCL thresholds perform in diverse populations and whether combining cervical length with other biomarkers could improve predictive accuracy.
